Broncus Technologies develops and sells innovative solutions for diagnosing and treating lung diseases. The Company’s LungPoint® system allows physicians to plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its FleXNeedle™ catheter is used to obtain biopsy samples and access to hard-to-reach targets.
The acquisition allows PneumRx to further strengthen its intellectual property position with several foundational patents in the emphysema/interventional pulmonology space, block competing technologies and take additional segments of the pulmonary disease market.
If you would like to learn more information about this transaction contact us below.